Cargando…

Antiphospholipid Antibody Induced by Nivolumab

Nivolumab is a monoclonal antibody against the programmed death protein 1 and is used for patients with advanced melanoma. It is associated with potentially immune-related adverse events, including disorders of the skin, GI tract, and the thyroid; these disorders were successfully treated with predn...

Descripción completa

Detalles Bibliográficos
Autores principales: Aburahma, Ahmed, Aljariri Alhesan, Nour, Elounais, Farah, Abu Sitta, Emad
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5821982/
https://www.ncbi.nlm.nih.gov/pubmed/29581905
http://dx.doi.org/10.1155/2018/3106852

Ejemplares similares